Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Aug;91:311-320.
doi: 10.1016/j.appet.2015.04.062. Epub 2015 Apr 27.

Acute Responses to Opioidergic Blockade as a Biomarker of Hedonic Eating Among Obese Women Enrolled in a Mindfulness-Based Weight Loss Intervention Trial

Affiliations
Free PMC article
Randomized Controlled Trial

Acute Responses to Opioidergic Blockade as a Biomarker of Hedonic Eating Among Obese Women Enrolled in a Mindfulness-Based Weight Loss Intervention Trial

Ashley E Mason et al. Appetite. .
Free PMC article

Abstract

There are currently no commonly used or easily accessible 'biomarkers' of hedonic eating. Physiologic responses to acute opioidergic blockade, indexed by cortisol changes and nausea, may represent indirect functional measures of opioid-mediated hedonic eating drive and predict weight loss following a mindfulness-based intervention for stress eating. In the current study, we tested whether cortisol and nausea responses induced by oral ingestion of an opioidergic antagonist (naltrexone) correlated with weight and self-report measures of hedonic eating and predicted changes in these measures following a mindfulness-based weight loss intervention. Obese women (N = 88; age = 46.7 ± 13.2 years; BMI = 35.8 ± 3.8) elected to complete an optional sub-study prior to a 5.5-month weight loss intervention with or without mindfulness training. On two separate days, participants ingested naltrexone and placebo pills, collected saliva samples, and reported nausea levels. Supporting previous findings, naltrexone-induced cortisol increases were associated with greater hedonic eating (greater food addiction symptoms and reward-driven eating) and less mindful eating. Among participants with larger cortisol increases (+1 SD above mean), mindfulness participants (relative to control participants) reported greater reductions in food addiction symptoms, b = -0.95, SE(b) = 0.40, 95% CI [-1.74, -0.15], p = .021. Naltrexone-induced nausea was marginally associated with reward-based eating. Among participants who endorsed naltrexone-induced nausea (n = 38), mindfulness participants (relative to control participants) reported greater reductions in food addiction symptoms, b = -1.00, 95% CI [-1.85, -0.77], p = .024, and trended toward reduced reward-based eating, binge eating, and weight, post-intervention. Single assessments of naltrexone-induced cortisol increases and nausea responses may be useful time- and cost-effective biological markers to identify obese individuals with greater opioid-mediated hedonic eating drive who may benefit from weight loss interventions with adjuvant mindfulness training that targets hedonic eating.

Keywords: Cortisol; Hedonic eating; Mindfulness intervention; Naltrexone; Nausea.

Figures

Figure 1
Figure 1
Naltrexone-induced cortisol increases from 1 PM to 4 PM on placebo and naltrexone days at baseline.
Figure 2
Figure 2
Interaction of naltrexone-induced cortisol response and treatment arm (active control vs. mindfulness) as a predictor of changes in self-reported food addiction symptoms.
Figure 3
Figure 3
Interaction of naltrexone-induced nausea (present vs. absent) and treatment arm (active control vs. mindfulness) as a predictor of changes in self-report measures of food addiction and binge eating symptoms.

Similar articles

See all similar articles

Cited by 10 articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback